A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells - PubMed (original) (raw)
A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells
C Czerkinsky et al. J Immunol Methods. 1988.
Abstract
A novel assay system has been developed which is based on the ELISPOT methodology and employs a combination of two immunoenzyme visualization systems yielding distinct colour products. This variation permits the simultaneous enumeration of two different types of cell secreting antigenically distinct products. Optimal conditions for the concurrent detection of human mononuclear cells secreting IgG or IgA antibodies are described.
Similar articles
- Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection.
Jones PD, Ada GL. Jones PD, et al. J Virol. 1986 Nov;60(2):614-9. doi: 10.1128/JVI.60.2.614-619.1986. J Virol. 1986. PMID: 3773053 Free PMC article. - Enumeration of human immunoglobulin-secreting cells by the ELISA-plaque method: IgE and IgG isotypes.
Holt PG, Cameron KJ, Stewart GA, Sedgwick JD, Turner KJ. Holt PG, et al. Clin Immunol Immunopathol. 1984 Jan;30(1):159-64. doi: 10.1016/0090-1229(84)90017-5. Clin Immunol Immunopathol. 1984. PMID: 6365382 - Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue.
Ogawa T, Tarkowski A, McGhee ML, Moldoveanu Z, Mestecky J, Hirsch HZ, Koopman WJ, Hamada S, McGhee JR, Kiyono H. Ogawa T, et al. J Immunol. 1989 Feb 15;142(4):1150-8. J Immunol. 1989. PMID: 2644350 - In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus.
Yarchoan R, Murphy BR, Strober W, Clements ML, Nelson DL. Yarchoan R, et al. J Immunol. 1981 Nov;127(5):1958-63. J Immunol. 1981. PMID: 7299119 - Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H. Tamura S, et al. Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
Cited by
- Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.
Qadri F, Ahmed F, Karim MM, Wenneras C, Begum YA, Abdus Salam M, Albert MJ, McGhee JR. Qadri F, et al. Clin Diagn Lab Immunol. 1999 Nov;6(6):812-8. doi: 10.1128/CDLI.6.6.812-818.1999. Clin Diagn Lab Immunol. 1999. PMID: 10548569 Free PMC article. - The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.
Asaduzzaman M, Ryan ET, John M, Hang L, Khan AI, Faruque AS, Taylor RK, Calderwood SB, Qadri F. Asaduzzaman M, et al. Infect Immun. 2004 Aug;72(8):4448-54. doi: 10.1128/IAI.72.8.4448-4454.2004. Infect Immun. 2004. PMID: 15271902 Free PMC article. - Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide.
Colino J, Outschoorn I. Colino J, et al. Infect Immun. 1998 Feb;66(2):505-13. doi: 10.1128/IAI.66.2.505-513.1998. Infect Immun. 1998. PMID: 9453603 Free PMC article. - Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.
Guy B. Guy B. Clin Diagn Lab Immunol. 2002 Jul;9(4):753-62. doi: 10.1128/cdli.9.4.753-762.2002. Clin Diagn Lab Immunol. 2002. PMID: 12093669 Free PMC article. Review. No abstract available. - Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.
Güereña-Burgueño F, Hall ER, Taylor DN, Cassels FJ, Scott DA, Wolf MK, Roberts ZJ, Nesterova GV, Alving CR, Glenn GM. Güereña-Burgueño F, et al. Infect Immun. 2002 Apr;70(4):1874-80. doi: 10.1128/IAI.70.4.1874-1880.2002. Infect Immun. 2002. PMID: 11895950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous